|
1
|
Zhang XY and Zhang PY: Gastric cancer:
Somatic genetics as a guide to therapy. J Med Genet. 54:305–312.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Z, Lei H, Luo M, Wang Y, Dong L, Ma Y,
Liu C, Song W, Wang F, Zhang J, et al: DNA methylation
downregulated mir-10b acts as a tumor suppressor in gastric cancer.
Gastric Cancer. 18:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng EK, Chong WW, Jin H, Lam EK, Shin VY,
Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of
microRNAs in plasma of patients with colorectal cancer: A potential
marker for colorectal cancer screening. Gut. 58:1375–1381. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loffeld RJ, Willems I, Flendrig JA and
Arends JW: Helicobacter pylori and gastric carcinoma.
Histopathology. 17:537–541. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Recavarren-Arce S, León-Barúa R, Cok J,
Berendson R, Gilman RH, Ramírez-Ramos A, Rodríguez C and Spira WM:
Helicobacter pylori and progressive gastric pathology that
predisposes to gastric cancer. Scand J Gastroenterol Suppl.
181:51–57. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang B, Yong H, Zhu H, Ni D, Tang S, Zhang
S, Wang W, Zhou Y, Zhao W, Ding G, et al: Abnormal amphiregulin
expression correlates with gastric cancer prognosis. Oncotarget.
7:76684–76692. 2016.PubMed/NCBI
|
|
8
|
Abu-Farha M, Al-Khairi I, Cherian P,
Chandy B, Sriraman D, Alhubail A, Al-Refaei F, AlTerki A and
Abubaker J: Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression
levels in obesity and T2D. Lipids Health Dis. 15:1812016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Masuko K: Angiopoietin-like 4: A molecular
link between insulin resistance and rheumatoid arthritis. J Orthop
Res. 35:939–943. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parri M, Pietrovito L, Grandi A,
Campagnoli S, De Camilli E, Bianchini F, Marchiò S, Bussolino F,
Jin B, Sarmientos P, et al: Angiopoietin-like 7, a novel
pro-angiogenetic factor over-expressed in cancer. Angiogenesis.
17:881–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo L, Li SY, Ji FY, Zhao YF, Zhong Y, Lv
XJ, Wu XL and Qian GS: Role of Angptl4 in vascular permeability and
inflammation. Inflamm Res. 63:13–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu P, Goh YY, Chin HFA, Kersten S and Tan
NS: Angiopoietin-like 4: A decade of research. Biosci Rep.
32:211–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan MJ, Teo Z, Sng MK, Zhu P and Tan NS:
Emerging roles of angiopoietin-like 4 in human cancer. Mol Cancer
Res. 10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim SH, Park YY, Kim SW, Lee JS, Wang D
and DuBois RN: ANGPTL4 induction by prostaglandin E2 under hypoxic
conditions promotes colorectal cancer progression. Cancer Res.
71:7010–7020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakayama T, Hirakawa H, Shibata K, Nazneen
A, Abe K, Nagayasu T and Taguchi T: Expression of angiopoietin-like
4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous
invasion and distant metastasis. Oncol Rep. 25:929–935. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ifon ET, Pang AL, Johnson W, Cashman K,
Zimmerman S, Muralidhar S, Chan WY, Casey J and Rosenthal LJ: U94
alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis
of prostate cancer cell line PC3. Cancer Cell Int. 5:192005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ayaz L, Görür A, Yaroğlu HY, Özcan C and
Tamer L: Differential expression of microRNAs in plasma of patients
with laryngeal squamous cell carcinoma: Potential early-detection
markers for laryngeal squamous cell carcinoma. J Cancer Res Clin
Oncol. 139:1499–1506. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiodoni C, Colombo MP and Sangaletti S:
Matricellular proteins: From homeostasis to inflammation, cancer,
and metastasis. Cancer Metastasis Rev. 29:295–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bornstein P: Matricellular proteins: An
overview. J Cell Commun Signal. 3:163–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arnold SA and Brekken RA: SPARC: A
matricellular regulator of tumorigenesis. J Cell Commun Signal.
3:255–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC,
Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, et al: Angiopoietin-like
4 protein elevates the prosurvival intracellular
O2(−):H2O2 ratio and confers
anoikis resistance to tumors. Cancer Cell. 19:401–415. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Wong CC, Wei H, Gilkes DM,
Korangath P, Chaturvedi P, Schito L, Chen J, Krishnamachary B,
Winnard PT Jr, et al: HIF-1-dependent expression of
angiopoietin-like 4 and L1CAM mediates vascular metastasis of
hypoxic breast cancer cells to the lungs. Oncogene. 31:1757–1770.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakayama T, Hirakawa H, Shibata K, Abe K,
Nagayasu T and Taguchi T: Expression of angiopoietin-like 4 in
human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep.
24:599–606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Yu X, Xie J, Zhan M, Yu Z, Xie L,
Zeng H, Zhang F, Chen G, Yi X, et al: ANGPTL2/LILRB2 signaling
promotes the propagation of lung cancer cells. Oncotarget.
6:21004–21015. 2015.PubMed/NCBI
|
|
26
|
Kikuchi R, Tsuda H, Kozaki K, Kanai Y,
Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J and Imoto I:
Frequent inactivation of a putative tumor suppressor,
angiopoietin-like protein 2, in ovarian cancer. Cancer Res.
68:5067–5075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshinaga T, Shigemitsu T, Nishimata H,
Takei T and Yoshida M: Angiopoietin-like protein 2 is a potential
biomarker for gastric cancer. Mol Med Rep. 11:2653–2658. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ,
Tan CK, Lam CR, Sng MK, Leong DT, Tan SM, et al: ANGPTL4 modulates
vascular junction integrity by integrin signaling and disruption of
intercellular VE-cadherin and claudin-5 clusters. Blood.
118:3990–4002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Young K and Chau I: Targeted therapies for
advanced oesophagogastric cancer: Recent progress and future
directions. Drugs. 76:13–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ajani JA: Evolving chemotherapy for
advanced gastric cancer. Oncologist. 10 Suppl 3:49–58. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Cutsem E, Dicato M, Geva R, Arber N,
Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M,
Glynne-Jones R, et al: The diagnosis and management of gastric
cancer: Expert discussion and recommendations from the 12th
ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Ann Oncol. 22 Suppl 5:v1–v9. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kostova I: Platinum complexes as
anticancer agents. Recent Patents Anticancer Drug Discov. 1:1–22.
2006. View Article : Google Scholar
|
|
33
|
Sun Y, Long J and Zhou Y:
Angiopoietin-like 4 promotes melanoma cell invasion and survival
through aldolase A. Oncol Lett. 8:211–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
